Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DR26F0VX9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,879
Award facts
- Contract value 100% obligated
- $9,879.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,879.12 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pens on October 29, 2025, with completion targeted for November 20, 2025. This competitively awarded, firm fixed-price order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will perform the work at its corporate office location in Conshohocken, Pennsylvania. Tezspire is a biologic medication used primarily in the treatment of moderate-to-severe eosinophilic or allergic asthma, indicating this order supports military healthcare supply chain requirements.
AmerisourceBergen Drug Corp's comprehensive federal contract portfolio with the Defense Logistics Agency demonstrates its critical role as a major pharmaceutical vendor for military and veteran healthcare systems. The company's DLA Troop Support Medical prime contract functions as a global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. No set-aside designation was applied to this delivery order, reflecting AmerisourceBergen's ability to compete successfully in open federal procurements. The contract award supports the broader DLA mission of providing essential medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0VX9?
SPE2DR26F0VX9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26F0VX9 worth?
The government has obligated $9,879 on SPE2DR26F0VX9.
Is contract SPE2DR26F0VX9 an order under another contract?
Yes. SPE2DR26F0VX9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0VX9 competed?
The extent of competition for SPE2DR26F0VX9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award